
Share on:
Citoxlab acquired AccelLAB, a Canadian clinical research organization specialized in the pre-clinical assessment of new medical devices. The move complements Citoxlab’s core business that focuses on drug development.
AccelLAB was founded in 2004 with a focus on development of new cardiac stents, valves, pacemakers, etc. Its services were recently enlarged to other specialties such as orthopaedics, Ear, Nose and Throat and dermatology.
AccelLAB is staffed by ~100 employees, and its facilities include operating rooms, laboratories, a medical imaging department (scanning and MRI) and clinical pathology and histopathology laboratories. Following this acquisition, Dr. Guy Leclerc remains the Managing Director of AccelLAB.
Source: CiToxLAB
RELATED ARTICLES
Autocam Medical Announces $70 Million Manufacturing Expansion
Jun 17 2025 , Julie A. Vetalice
Strategic Expansion at the Heart of German Precision Manufacturing
Jun 08 2025 , Acrotec Medtech